EPOGEN

This brand name is authorized in Ecuador, United States

Active ingredients

The drug EPOGEN contains one active pharmaceutical ingredient (API):

1 Epoetin alfa UNII 64FS3BFH5W - EPOETIN

Epoetin alfa is a glycoprotein hormone produced primarily by the kidney in response to hypoxia and is the key regulator of red blood cell (RBC) production. Epoetin alfa is involved in all phases of erythroid development, and has its principal effect at the level of erythroid precursors. Read about Epoetin alfa

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EPOGEN Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B03XA01	Erythropoietin	B Blood and blood forming organs → B03 Antianemic preparations → B03X Other antianemic preparations → B03XA Other antianemic preparations
Discover more medicines within B03XA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 91-MBE-0317, 94-MBE-0417
Country: US	FDA, National Drug Code	Identifier(s): 55513-126, 55513-144, 55513-148, 55513-267, 55513-283, 55513-478